As Chinese research firm may have made news by becoming the first organisation globally to enter phase-II of clinical trials to find a vaccine against the novel coronavirus disease (Covid-19) but Indian drugmakers are not far behind.
Six Indian drugmakers are in race to make a Covid-19 vaccine and, on basis of what these developers say, India may have a vaccine by next year as most candidates are already in animal-trial phase.
Gagandeep Kang, the vice-chair of the Coalition for Epidemic Preparedness Innovations, said Cadila Healthcare (Zydus Cadila), Serum Institute of India, Bharat Biotech, Indian Immunologicals, Mynvax, and Biological E

)